The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127363851 12736385 1 I 20160802 20160830 20160913 20160913 EXP NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-123292 RANBAXY 55.00 YR M Y 0.00000 20160913 OT NO NO

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127363851 12736385 1 PS OXALIPLATIN. OXALIPLATIN 1 Intravenous (not otherwise specified) 153 MG Y U 202922 153 MG
127363851 12736385 2 SS OXALIPLATIN. OXALIPLATIN 1 Intravenous (not otherwise specified) 153 MG Y U 202922 153 MG
127363851 12736385 3 SS OXALIPLATIN. OXALIPLATIN 1 Intravenous (not otherwise specified) 153 MG Y U 202922 153 MG
127363851 12736385 4 SS CALCIUM FOLINATE LEUCOVORIN CALCIUM 1 Intravenous (not otherwise specified) 100 MG U U 0 100 MG
127363851 12736385 5 SS CALCIUM FOLINATE LEUCOVORIN CALCIUM 1 Intravenous (not otherwise specified) 100 MG U U 0 100 MG
127363851 12736385 6 SS CALCIUM FOLINATE LEUCOVORIN CALCIUM 1 Intravenous (not otherwise specified) 100 MG U U 0 100 MG
127363851 12736385 7 SS Fluoroblastin FLUOROURACIL 1 Intravenous (not otherwise specified) 900 MG 0 900 MG
127363851 12736385 8 SS Fluoroblastin FLUOROURACIL 1 Intravenous (not otherwise specified) 900 MG 0 900 MG
127363851 12736385 9 SS Fluoroblastin FLUOROURACIL 1 Unknown 900 MG 0 900 MG
127363851 12736385 10 C EMEND APREPITANT 1 Unknown 125 MG U U 0 125 MG
127363851 12736385 11 C ONDANSETRON ONDANSETRON 1 Unknown 8 MG U U 0 8 MG
127363851 12736385 12 C KLEXANE ENOXAPARIN 1 Subcutaneous 60 MG U U 0 60 MG
127363851 12736385 13 C DEXAMETHASONE. DEXAMETHASONE 1 Oral 16 MG U U 0 16 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127363851 12736385 1 Rectal cancer
127363851 12736385 4 Rectal cancer
127363851 12736385 7 Rectal cancer
127363851 12736385 10 Prophylaxis of nausea and vomiting
127363851 12736385 11 Premedication
127363851 12736385 12 Deep vein thrombosis
127363851 12736385 13 Premedication

Outcome of event

Event ID CASEID OUTC COD
127363851 12736385 OT
127363851 12736385 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127363851 12736385 Abdominal pain upper
127363851 12736385 Cold sweat
127363851 12736385 Nausea
127363851 12736385 Restlessness

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127363851 12736385 1 20160802 0
127363851 12736385 2 20160705 0
127363851 12736385 3 20160704 0
127363851 12736385 4 20160705 0
127363851 12736385 5 20160704 0
127363851 12736385 6 20160802 0
127363851 12736385 7 20160705 0
127363851 12736385 8 20160704 0
127363851 12736385 9 20160802 0